Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

The Lancet Neurology

Volumn 8, Issue 12, 2009, Pages 1128-1139

  Rodriguez Oroz, Maria C ^a,b   Jahanshahi, Marjan ^c   Krack, Paul ^d,e   Litvan, Irene ^f   Macias, Raúl ^g   Bezard, Erwan ^h   Obeso, José A ^a,b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^f University of Louisville School of Medicine   (United States)

^g CENTRO INTERNACIONAL DE RESTAURACIÓN NEUROLÓGICA CIREN   (Cuba)

^h UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AKINESIA; DOPAMINERGIC ACTIVITY; HUMAN; MENTAL DISEASE; MUSCLE TONE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RIGIDITY; TREMOR;

AGED; COGNITION DISORDERS; EXECUTIVE FUNCTION; HUMANS; MENTAL DISORDERS; MIDDLE AGED; MODELS, BIOLOGICAL; MOVEMENT; MOVEMENT DISORDERS; MUSCLE HYPOTONIA; PARKINSON DISEASE; TREMOR;

EID: 72149101615     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(09)70293-5     Document Type: Review

References (127)

1. Wilson S. Disorders of motility and tone. Lancet 206 (1925) 1-10 53-62, 169-78.
2. Marsden C.D. The mysterious motor function of the basal ganglia: the Robert Wartenberg Lecture. Neurology 32 (1982) 514-539
3. Hornykiewicz O. Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: the view of an eyewitness. Neurodegener Dis 5 (2008) 114-117
4. Obeso J.A., Rodríguez-Oroz M.C., Benitez-Temino B., et al. Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord 23 suppl 3 (2008) S548-S559
5. Schwab R.S., England A.C., and Peterson E. Akinesia in Parkinson's disease. Neurology 9 (1959) 65-72
6. Morris M.E., Iansek R., Matyas T.A., and Summers J.J. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain 119 (1996) 551-568
7. Andrews C.J., Burke D., and Lance J.W. The response to muscle stretch and shortening in Parkinsonian rigidity. Brain 95 (1972) 795-812
8. Broussolle E., Krack P., Thobois S., et al. Contribution of Jules Froment to the study of parkinsonian rigidity. Mov Disord 22 (2007) 909-914
9. Albin R.L., Young A.B., and Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci 12 (1989) 366-375
10. Crossman A.R., Clarke C.E., Boyce S., et al. MPTP-induced parkinsonism in the monkey: neurochemical pathology, complications of treatment and pathophysiological mechanisms. Can J Neurol Sci 14 (1987) 428-435
11. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13 (1990) 281-285
12. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., DeLong M.R., and Olanow C.W. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 47 4 suppl 1 (2000) S22-S32
13. Marsden C.D., and Obeso J.A. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 117 (1994) 877-897
14. Brown P., and Eusebio A. Paradoxes of functional neurosurgery: clues from basal ganglia recordings. Mov Disord 23 (2008) 12-20
15. Rodriguez-Oroz M.C., Rodriguez M., Guridi J., et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 124 (2001) 1777-1790
16. Lin T.P., Carbon M., Tang C., et al. Metabolic correlates of subthalamic nucleus activity in Parkinson's disease. Brain 131 (2008) 1373-1380
17. Limousin P., Brown R.G., Jahanshahi M., et al. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. Brain 122 (1999) 315-327
18. Trost M., Su S., Su P., et al. Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage 31 (2006) 301-307
19. Hikosaka O., Nakamura K., Sakai K., and Nakahara H. Central mechanisms of motor skill learning. Curr Opin Neurobiol 12 (2002) 217-222
20. Seger C.A. The basal ganglia in human learning. Neuroscientist 12 (2006) 285-290
21. Bjorklund A., and Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci 30 (2007) 194-202
22. Sawamoto N., Piccini P., Hotton G., et al. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 131 (2008) 1294-1302
23. Marklund P., Larsson A., Elgh E., et al. Temporal dynamics of basal ganglia under-recruitment in Parkinson's disease: transient caudate abnormalities during updating of working memory. Brain 132 (2009) 336-346
24. Moore R.Y., Whone A.L., and Brooks D.J. Extrastriatal monoamine neuron function in Parkinson's disease: an 18F-dopa PET study. Neurobiol Dis 29 (2008) 381-390
25. Hoogendijk W.J., Pool C.W., Troost D., et al. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain 118 (1995) 131-143
26. Yuste R., MacLean J.N., Smith J., and Lansner A. The cortex as a central pattern generator. Nat Rev Neurosci 6 (2005) 477-483
27. Buhusi C.V., and Meck W.H. What makes us tick? Functional and neural mechanisms of interval timing. Nat Rev Neurosci 6 (2005) 755-765
28. Meck W.H. Neuroanatomical localization of an internal clock: a functional link between mesolimbic, nigrostriatal, and mesocortical dopaminergic systems. Brain Res 1109 (2006) 93-107
29. Jahanshahi M., Jones C.R., Dirnberger G., and Frith C.D. The substantia nigra pars compacta and temporal processing. J Neurosci 26 (2006) 12266-12273
30. Pastor M.A., Artieda J., Jahanshahi M., and Obeso J.A. Time estimation and reproduction is abnormal in Parkinson's disease. Brain 115 (1992) 211-225
31. Drew M.R., Simpson E.H., Kellendonk C., et al. Transient overexpression of striatal D2 receptors impairs operant motivation and interval timing. J Neurosci 27 (2007) 7731-7739
32. Leblois A., Meissner W., Bezard E., et al. Temporal and spatial alterations in GPi neuronal encoding might contribute to slow down movement in Parkinsonian monkeys. Eur J Neurosci 24 (2006) 1201-1208
33. Basso M.A., Powers A.S., and Evinger C. An explanation for reflex blink hyperexcitability in Parkinson's disease. I. Superior colliculus. J Neurosci 16 (1996) 7308-7317
34. Hallett M., and Khoshbin S. A physiological mechanism of bradykinesia. Brain 103 (1980) 301-314
35. Mazzoni P., Hristova A., and Krakauer J.W. Why don't we move faster? Parkinson's disease, movement vigor, and implicit motivation. J Neurosci 27 (2007) 7105-7116
36. Berardelli A., Dick J.P., Rothwell J.C., et al. Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 49 (1986) 1273-1279
37. Espay A.J., Beaton D.E., Morgante F., et al. Impairments of speed and amplitude of movement in Parkinson's disease: a pilot study. Mov Disord 24 (2009) 1001-1008
38. Yelnik J., Francois C., and Percheron G. Spatial relationships between striatal axonal endings and pallidal neurons in macaque monkeys. Adv Neurol 74 (1997) 45-56
39. Guthrie M., Myers C.E., and Gluck M.A. A neurocomputational model of tonic and phasic dopamine in action selection: a comparison with cognitive deficits in Parkinson's disease. Behav Brain Res 200 (2009) 48-59
40. Redgrave P., Prescott T.J., and Gurney K. The basal ganglia: a vertebrate solution to the selection problem?. Neuroscience 89 (1999) 1009-1023
41. Boraud T., Bezard E., Bioulac B., and Gross C.E. Ratio of inhibited-to-activated pallidal neurons decreases dramatically during passive limb movement in the MPTP-treated monkey. J Neurophysiol 83 (2000) 1760-1763
42. Escola L., Michelet T., Douillard G., et al. Disruption of the proprioceptive mapping in the medial wall of parkinsonian monkeys. Ann Neurol 52 (2002) 581-587
43. Goldberg J.A., Boraud T., Maraton S., et al. Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J Neurosci 22 (2002) 4639-4653
44. Filion M., Tremblay L., and Bedard P.J. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 444 (1988) 165-176
45. Mallet N., Ballion B., Le Moine C., and Gonon F. Cortical inputs and GABA interneurons imbalance projection neurons in the striatum of parkinsonian rats. J Neurosci 26 (2006) 3875-3884
46. Taverna S., Ilijic E., and Surmeier D.J. Recurrent collateral connections of striatal medium spiny neurons are disrupted in models of Parkinson's disease. J Neurosci 28 (2008) 5504-5512
47. Calabresi P., Gubellini P., Centonze D., et al. Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci 20 (2000) 8443-8451
48. Dejean C., Gross C.E., Bioulac B., and Boraud T. Dynamic changes in the cortex-basal ganglia network after dopamine depletion in the rat. J Neurophysiol 100 (2008) 385-396
49. Hammond C., Bergman H., and Brown P. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci 30 (2007) 357-364
50. Eusebio A., Pogosyan A., Wang S., et al. Resonance in subthalamo-cortical circuits in Parkinson's disease. Brain 132 (2009) 2139-2150
51. Brown P. Oscillatory nature of human basal ganglia activity: relationship to the pathophysiology of Parkinson's disease. Mov Disord 18 (2003) 357-363
52. Alonso-Frech F., Zamarbide I., Alegre M., et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 129 (2006) 1748-1757
53. Gross C., Feger J., Seal J., Haramburu P., and Bioulac B. Neuronal activity in area 4 and movement parameters recorded in trained monkeys after unilateral lesion of the substantia nigra. Exp Brain Res 7 (1983) 181-193
54. Mink J.W., and Thach W.T. Basal ganglia motor control. II. Late pallidal timing relative to movement onset and inconsistent pallidal coding of movement parameters. J Neurophysiol 65 (1991) 301-329
55. Escola L., Michelet T., Macia F., et al. Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: a clue to the pathophysiology of akinesia?. Brain 126 (2003) 95-114
56. Kita H., Tachibana Y., Nambu A., and Chiken S. Balance of monosynaptic excitatory and disynaptic inhibitory responses of the globus pallidus induced after stimulation of the subthalamic nucleus in the monkey. J Neurosci 25 (2005) 8611-8619
57. Nambu A., Tokuno H., Hamada I., et al. Excitatory cortical inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol 84 (2000) 289-300
58. Mortimer J.A., and Webster D.D. Evidence for a quantitative association between EMG stretch responses and Parkinsonian rigidity. Brain Res 162 (1979) 169-173
59. Delwaide P.J., Pepin J.L., and de Noordhout A.M. Short-latency autogenic inhibition in patients with Parkinsonian rigidity. Ann Neurol 30 (1991) 83-89
60. Rothwell J.C., Obeso J.A., Traub M.M., and Marsden C.D. The behaviour of the long-latency stretch reflex in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 46 (1983) 35-44
61. Lefaucheur J.P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation. Clin Neurophysiol 116 (2005) 244-253
62. Cantello R., Gianelli M., Civardi C., and Mutani R. Pathophysiology of Parkinson's disease rigidity. Role of corticospinal motor projections. Adv Neurol 69 (1996) 129-133
63. Mir P., Matsunaga K., Gilio F., et al. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease. Neurology 64 (2005) 1906-1912
64. Delwaide P.J., Pepin J.L., and de Noordhout A.M. The audiospinal reaction in parkinsonian patients reflects functional changes in reticular nuclei. Ann Neurol 33 (1993) 63-69
65. Rodriguez M.C., Guridi O.J., Alvarez L., et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 13 suppl 3 (1998) 111-118
66. Hirai T., Miyazaki M., Nakajima H., et al. The correlation between tremor characteristics and the predicted volume of effective lesions in stereotaxic nucleus ventralis intermedius thalamotomy. Brain 106 (1983) 1001-1018
67. Rivlin-Etzion M., Marmor O., Saban G., et al. Low-pass filter properties of basal ganglia cortical muscle loops in the normal and MPTP primate model of parkinsonism. J Neurosci 28 (2008) 633-649
68. Bevan M.D., Magill P.J., Terman D., et al. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 25 (2002) 525-531
69. Garcia-Cabezas M.A., Martinez-Sanchez P., Sanchez-Gonzalez M.A., et al. Dopamine innervation in the thalamus: monkey versus rat. Cereb Cortex 19 (2009) 424-434
70. Lanciego J.L., Gonzalo N., Castle M., et al. Thalamic innervation of striatal and subthalamic neurons projecting to the rat entopeduncular nucleus. Eur J Neurosci 19 (2004) 1267-1277
71. Otsuka M., Ichiya Y., Kuwabara Y., et al. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms. J Neurol Sci 136 (1996) 169-173
72. Vidailhet M., Jedynak C.P., Pollak P., and Agid Y. Pathology of symptomatic tremors. Mov Disord 13 suppl 3 (1998) 49-54
73. Foltynie T., Brayne C.E., Robbins T.W., and Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127 (2004) 550-560
74. Muslimovic D., Post B., Speelman J.D., and Schmand B. Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology 65 (2005) 1239-1245
75. Elgh E., Domellof M., Linder J., Edstrom M., Stenlund H., and Forsgren L. Cognitive function in early Parkinson's disease: a population-based study. Eur J Neurol (2009) 10.1111/j.1468-1331.2009.02707.x published online June 15.
76. Taylor A.E., Saint-Cyr J.A., and Lang A.E. Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow. Brain 109 (1986) 845-883
77. Owen A.M., James M., Leigh P.N., et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 115 (1992) 1727-1751
78. Cools R., Barker R.A., Sahakian B.J., and Robbins T.W. Mechanisms of cognitive set flexibility in Parkinson's disease. Brain 124 (2001) 2503-2512
79. Dirnberger G., Frith C.D., and Jahanshahi M. Executive dysfunction in Parkinson's disease is associated with altered pallidal-frontal processing. Neuroimage 25 (2005) 588-599
80. Brown R.G., and Marsden C.D. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 114 (1991) 215-231
81. Brown R.G., Soliveri P., and Jahanshahi M. Executive processes in Parkinson's disease-random number generation and response suppression. Neuropsychologia 36 (1998) 1355-1362
82. Brown R.G., and Marsden C.D. An investigation of the phenomenon of "set" in Parkinson's disease. Mov Disord 3 (1988) 152-161
83. Levin B.E., Llabre M.M., Reisman S., et al. Visuospatial impairment in Parkinson's disease. Neurology 41 (1991) 365-369
84. Lees A.J., and Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 106 (1983) 257-270
85. Whittington C.J., Podd J., and Kan M.M. Recognition memory impairment in Parkinson's disease: power and meta-analyses. Neuropsychology 14 (2000) 233-246
86. Wilkinson L., Lagnado D.A., Quallo M., and Jahanshahi M. The effect of feedback on non-motor probabilistic classification learning in Parkinson's disease. Neuropsychologia 46 (2008) 2683-2695
87. Wilkinson L., and Jahanshahi M. The striatum and probabilistic implicit sequence learning. Brain Res 1137 (2007) 117-130
88. Cooper J.A., Sagar H.J., Doherty S.M., et al. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease. A follow-up study of untreated patients. Brain 115 (1992) 1701-1725
89. Gotham A.M., Brown R.G., and Marsden C.D. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain 111 (1988) 299-321
90. Cools R., Altamirano L., and D'Esposito M. Reversal learning in Parkinson's disease depends on medication status and outcome valence. Neuropsychologia 44 (2006) 1663-1673
91. Swainson R., Rogers R.D., Sahakian B.J., et al. Probabilistic learning and reversal deficits in patients with Parkinson's disease or frontal or temporal lobe lesions: possible adverse effects of dopaminergic medication. Neuropsychologia 38 (2000) 596-612
92. Bruck A., Portin R., Lindell A., et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 311 (2001) 81-84
93. Marie R.M., Barre L., Dupuy B., et al. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 260 (1999) 77-80
94. Broussolle E., Dentresangle C., Landais P., et al. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease. J Neurol Sci 166 (1999) 141-151
95. Scatton B., Javoy-Agid F., Rouquier L., et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res 275 (1983) 321-328
96. Rakshi J.S., Uema T., Ito K., et al. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease: a 3D [(18)F]dopa-PET study. Brain 122 (1999) 1637-1650
97. Owen A.M., Doyon J., Dagher A., et al. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions. Brain 121 (1998) 949-965
98. Dagher A., Owen A.M., Boecker H., and Brooks D.J. The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease. Brain 124 (2001) 1020-1032
99. Cools R., Stefanova E., Barker R.A., et al. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125 (2002) 584-594
100. Monchi O., Petrides M., Mejia-Constain B., and Strafella A.P. Cortical activity in Parkinson's disease during executive processing depends on striatal involvement. Brain 130 (2007) 233-244
101. Decamp E., and Schneider J.S. Attention and executive function deficits in chronic low-dose MPTP-treated non-human primates. Eur J Neurosci 20 (2004) 1371-1378
102. Schneider J.S. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys. Brain Res 534 (1990) 25-36
103. Dubois B., Danze P., Pillon B., Cusimano G., Lhermite F., and Agid Y. Cholinergic-dependent cognitive deficits in Parkinson's disease. Ann Neurol 22 (1987) 26-30
104. Dubois B., Pillon B., Lhermite F., and Agid Y. Cholingergic deficiency and frontal dysfunction in Parkinson's disease. Ann Neurol 28 (1990) 117-121
105. Calabresi P., Picconi B., Parnetti L., and Di Filippo M. A convergent model of cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. Lancet Neurol 5 (2006) 974-983
106. Menza M.A., Golbe L.I., Cody R.A., and Forman N.E. Dopamine-related personality traits in Parkinson's disease. Neurology 43 (1993) 505-508
107. Glosser G., Clark C., Freundlich B., et al. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 10 (1995) 201-206
108. Kulisevsky J., Pagonabarraga J., Pascual-Sedano B., et al. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 23 (2008) 1889-1896
109. Voon V., Fernagut P.-O., Wickens J., et al. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol 8 (2009) 1140-1149
110. Aarsland D., Bronnick K., Alves G., et al. The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. J Neurol Neurosurg Psychiatry 80 (2009) 928-930
111. Bodi N., Keri S., Nagy H., et al. Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients. Brain 132 (2009) 2385-2395
112. Martinez-Martin P., Carod-Artal F.J., da Silveira Ribeiro L., et al. Longitudinal psychometric attributes, responsiveness, and importance of change: an approach using the SCOPA-psychosocial questionnaire. Mov Disord 23 (2008) 1516-1523
113. Reijnders J.S., Ehrt U., Weber W.E., et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord 23 (2008) 183-189
114. Schrag A., Jahanshahi M., and Quinn N. What contributes to quality of life in patients with Parkinson's disease?. J Neurol Neurosurg Psychiatry 69 (2000) 308-312
115. Leentjens A.F., Dujardin K., Marsh L., et al. Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23 (2008) 2004-2014
116. Pedersen K.F., Larsen J.P., Alves G., and Aarsland D. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study. Parkinsonism Relat Disord 15 (2009) 295-299
117. Zgaljardic D.J., Borod J.C., Foldi N.S., et al. Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease. Cogn Behav Neurol 20 (2007) 184-192
118. Lauterbach E.C. The neuropsychiatry of Parkinson's disease. Minerva Med 96 (2005) 155-173
119. Leentjens A.F., Dujardin K., Marsh L., et al. Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 23 (2008) 2015-2025
120. Cummings J.L., Diaz C., Levy M., et al. Neuropsychiatric syndromes in neurodegenerative disease: frequency and signficance. Semin Clin Neuropsychiatry 1 (1996) 241-247
121. Deblieck C., and Wu A.D. Neuroimaging of nonmotor features of Parkinson's disease. Rev Neurol Dis 5 (2008) 125-133
122. Remy P., Doder M., Lees A., et al. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128 (2005) 1314-1322
123. Mayeux R., Stern Y., Williams J.B., et al. Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 143 (1986) 756-759
124. Shiba M., Bower J.H., Maraganore D.M., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study. Mov Disord 15 (2000) 669-677
125. Maricle R.A., Nutt J.G., and Carter J.H. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings. Mov Disord 10 (1995) 329-332
126. Richard I.H., Frank S., McDermott M.P., et al. The ups and downs of Parkinson disease: a prospective study of mood and anxiety fluctuations. Cogn Behav Neurol 17 (2004) 201-207
127. Czernecki V., Schupbach M., Yaici S., et al. Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom. Mov Disord 23 (2008) 964-969